Michaels Pharmaceuticals Private Limited
About Michaels Pharmaceuticals Private Limited
Data last updated:
Michaels Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the research and development sector. It was incorporated on 02 December 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999DL2016PTC308826. Its GSTIN is 09AAKCM6997M1ZB (Uttar Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sehad Bahadur and Poonam Devi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat No. 13 Block – D Pkt – 17 Sector – 3, New Delhi, Delhi, India – 110085.
As per the financials filed for FY 2025, the company reported a revenue of ₹56.08 Lakh, a growth of 36% compared to the previous year. For the same year it recorded a net profit of ₹80,771 (net margin 1.4%) and EBITDA of ₹2.2 Lakh (EBITDA margin 3.9%). Revenue has grown at a compounded annual rate (CAGR) of 19% over three years and 25% over five years.
As per MCA filings, the company has open charges of ₹10 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Michaels Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressFlat No. 13 Block – D Pkt – 17 Sector – 3, New Delhi, Delhi, India – 110085
- IndustryResearch & Development, Research & Development
To see the full contact details of Michaels Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Michaels Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Michaels Pharmaceuticals Private Limited, buy the company report.
Financials of Michaels Pharmaceuticals Private Limited
FY 2025 filings availableMichaels Pharmaceuticals Private Limited reported revenue of ₹56.08 Lakh (up 36% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 25% over five years, including 36% growth in the latest year. EBITDA fell 8% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.2 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹80,771 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.9% | ||||
| Net Profit Margin | 1.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Michaels Pharmaceuticals Private Limited, buy the company report.
Board of directors of Michaels Pharmaceuticals Private Limited
Michaels Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sehad Bahadur | Director | 18 Jan 2021 | 5 Years 9 Months | Current |
| Poonam Devi | Director | 02 Dec 2016 | 9 Years 11 Months | Current |
Peer comparison
Michaels Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Beecan Pharmaceuticals Private Limited | ₹56.75 Lakh (FY 2024) | 283.0% | Chandigarh, India | |||
| Clarianz Pharmaceuticals Private Limited | ₹56.53 Lakh (FY 2022) | -12.0% | Latur, Maharashtra, India | |||
| Michaels Pharmaceuticals Private Limitedthis company | ₹56.08 Lakh (FY 2025) | ₹80,771 | 1.4% | 36.0% | New Delhi, Delhi, India | |
| Criswell Pharmaceuticals Private Limited | ₹55.99 Lakh (FY 2025) | 6.0% | Agra, Uttar Pradesh, India | |||
| Lifewise Pharmaceuticals Private Limited | ₹55.82 Lakh (FY 2025) | -28.0% | Panchkula, Haryana, India | |||
| Aprecia Pharmaceuticals Private Limited | ₹55.54 Lakh (FY 2024) | 16.0% | Lucknow, Uttar Pradesh, India |
To see the full peer comparison of Michaels Pharmaceuticals Private Limited, buy the company report.
Auditor
Michaels Pharmaceuticals Private Limited is audited by POONAM ARORA AND CO for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| POONAM ARORA AND CO | FY 2017 | 531063 |
Shareholding
The shareholding of Michaels Pharmaceuticals Private Limited is on record for FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Michaels Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Jun 2025 | 101131660 | Canara Bank | ₹10 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Michaels Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Michaels Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Michaels Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAKCM6997M1ZB | Uttar Pradesh | Active | 12 Aug 2017 |
To see the full GST registrations and return filing status of Michaels Pharmaceuticals Private Limited, buy the company report.
Recent activity
Michaels Pharmaceuticals Private Limited has 3 board changes on record since 2016: 2 appointments and 1 cessation. The latest: Amar Bahadur ceased to be Director on 18 Jan 2021.
Frequently asked questions
Michaels Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in the research and development industry. It was incorporated on 02 December 2016 (10+ years old) and is registered under CIN U74999DL2016PTC308826.
Michaels Pharmaceuticals has 2 current directors:
- Sehad Bahadur - Director
- Poonam Devi - Director
The latest financial statements of Michaels Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Michaels Pharmaceuticals is 09AAKCM6997M1ZB, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Michaels Pharmaceuticals is U74999DL2016PTC308826. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Michaels Pharmaceuticals was incorporated on 02 December 2016, making it 10+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Michaels Pharmaceuticals by revenue are Beecan Pharmaceuticals Private Limited, Clarianz Pharmaceuticals Private Limited, Criswell Pharmaceuticals Private Limited, Lifewise Pharmaceuticals Private Limited, Aprecia Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Amar Bahadur ceased to be Director on 18 Jan 2021. Sehad Bahadur was appointed as Director on 18 Jan 2021. Poonam Devi was appointed as Director on 02 Dec 2016.
The registered office of Michaels Pharmaceuticals is at Flat No. 13 Block – D Pkt – 17 Sector – 3, New Delhi, Delhi, India – 110085.
Michaels Pharmaceuticals operates in the research and development industry.
Michaels Pharmaceuticals has open charges of ₹10 Lakh and no satisfied charges on record as per latest MCA filings.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
